T. Nagatomo

发表

Recent advances in structure, binding sites with ligands and pharmacological function of beta-adrenoceptors obtained by molecular biology and molecular modeling.

K. Koike, T. Nagatomo, 2000, Life sciences.

The effect of calcium and high-energy phosphate compounds on myocardial contracture in the newborn and adult rabbit.

G. Langer, J. Jarmakani, T. Nagatomo, 1978, Journal of molecular and cellular cardiology.

The Increase in β-Adrenergic Receptors in Lymphocytes Following Treatment with Xamoterol

Kenichi Watanabe, Kaoru Suzuki, A. Shibata, 1988 .

α1‐Adrenoceptor Subtypes in the Rat Ventricular Muscle

T. Nagatomo, S. Baba, H. Tsuchihashi, 1992, The Journal of pharmacy and pharmacology.

Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling.

S. Miura, M. Ishiguro, Takashi Nakamura, 2009, Life sciences.

Effects of neuraminidase and deoxyribonuclease on the beta-adrenergic receptors in rat heart.

T. Nagatomo, M. Sasaki, 1983, Japanese journal of pharmacology.

Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.

S. Imai, T. Nagatomo, H. Tsuchihashi, 1983, Japanese journal of pharmacology.

Abnormal fatty acid metabolism in patients with coronary vasospasm

Masahiro Ito, Kenichi Watanabe, M. Kodama, 1999, Annals of nuclear medicine.

Effect of hypoxia on myocardial high-energy phosphates in the neonatal mammalian heart.

G. Langer, J. Jarmakani, M. Nakazawa, 1978, The American journal of physiology.

A Novel 5-HT2 Antagonist, Sarpogrelate Hydrochloride, Shows Inhibitory Effects on Both Contraction and Relaxation Mediated by 5-HT Receptor Subtypes in Porcine Coronary Arteries

Kenichi Watanabe, M. Nakazawa, M. Rashid, 2000, Pharmacology.

Binding characteristics of 3H-CGP12177 to beta-adrenoceptors in rat myocardial membranes.

T. Nagatomo, H. Tsuchihashi, H. Yokoyama, 1989, Japanese journal of pharmacology.

Binding of [3H]Haloperidol to Dopamine D2 Receptors in the Rat Striatum

S. Kojima, T. Nagatomo, T. Sasaki, 1992, The Journal of pharmacy and pharmacology.

Cardiac sarcolemma: compositional adaptation to exercise.

R. Barnard, G. Tibbits, T. Nagatomo, 1981, Science.

Bopindolol: A Slowly Dissociating Antagonist from the β-Adrenoceptors in Guinea Pig Atria

M. Okuyama, J. Suzuki, Y. Hosohata, 1998, Pharmacology.

Identification of a key amino acid of the human 5-HT(2B) serotonin receptor important for sarpogrelate binding.

T. Komiyama, Habib Abul Muntasir, Takashi Nakamura, 2007, Journal of pharmacological sciences.

Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human β‐ and α1‐adrenoceptor subtypes

Maruf Ahmed, I. Muramatsu, T. Kakita, 2005, The Journal of pharmacy and pharmacology.

Binding and functional affinity of some newly synthesized phenethylamine and phenoxypropanolamine derivatives for their agonistic activity at recombinant human β3‐adrenoceptor

Maruf Ahmed, T. Nagao, H. Kurose, 2003, The Journal of pharmacy and pharmacology.

Assessment of Affinities of Propranolol and Bopindolol to Membranes from COS-7 Cell Transiently Transfected with Beta-1- and Beta-2-Adrenoceptors Using a Radioligand-Binding Assay Method

Kenichi Watanabe, T. Nagao, H. Kurose, 2000, Pharmacology.

Slow association of positively charged Ca2+ channel antagonist amlodipine to dihydropyridine receptor sites in rat brain membranes.

Y. Qu, K. Watanabe, K. Sugiyama, 1996, General pharmacology.

Beta-adrenoceptors: three-dimensional structures and binding sites for ligands.

M. Ishiguro, T. Nagatomo, T. Ohnuki, 2001, Japanese journal of pharmacology.

Beta3-adrenoceptors mediate relaxation of guinea pig taenia caecum by BRL37344A and BRL35135A.

I. Takayanagi, K. Koike, T. Nagatomo, 1997, European journal of pharmacology.

Assessment of binding affinity to 5-hydroxytryptamine 2A (5-HT2A) receptor and inverse agonist activity of naftidrofuryl: comparison with those of sarpogrelate.

Takashi Nakamura, M. Bhuiyan, Murad Hossain, 2009, Journal of pharmacological sciences.

Bopindolol Is a Slowly Dissociating β1-Adrenoceptor Antagonist When Compared to Other β-Blockers

K. Sasaki, J. Suzuki, Y. Hosohata, 1995 .

Bopindolol is a slowly dissociating beta 1-adrenoceptor antagonist when compared to other beta-blockers.

K. Sasaki, J. Suzuki, Y. Hosohata, 1995, Biological & pharmaceutical bulletin.

Differential inhibition by oxygen radicals of vasoactive amines-induced contractions in the porcine coronary artery.

M. Nakazawa, Maruf Ahmed, Habib Abul Muntasir, 2007, Biological & pharmaceutical bulletin.

Chronic Myocarditis and Angiotensin-II Receptor Antagonist (TCV-116)

Kenichi Watanabe, T. Inomata, T. Izumi, 1995 .

Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of exo- and endo-glycosidases and glycopeptidase.

T. Nagatomo, H. Tsuchihashi, 1985, Japanese journal of pharmacology.

Binding affinity of a newly synthesized 5-HT2 antagonist, AT-1015 (N-[2-[4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-piperidino]ethyl]-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate), in the rabbit platelet membrane.

M. Nakazawa, M. Rashid, Masatomo Watanabe, 2001, Biological & pharmaceutical bulletin.

Differences in lipid composition and fluidity of cardiac sarcolemma prepared from newborn and adult rabbits.

T. Konishi, T. Nagatomo, M. Sasaki, 1984, Biochemical medicine.

The effect of anoxia on membrane-bound ATPase and K+-p-nitrophenyl phosphatase activities in the rabbit heart

J. Jarmakani, K. Philipson, M. Nakazawa, 1978 .

Sustaining Effects of Bopindolol on Inhibitory Chronotropic Actions in Guinea Pig Atria

Kenichi Watanabe, J. Suzuki, Y. Hosohata, 1999, Pharmacology.

Effect of hypoxia on mechanical function in the neonatal mammalian heart.

G. Langer, J. Jarmakani, M. Nakazawa, 1978, The American journal of physiology.

Functions of 5-HT2A receptor and its antagonists in the cardiovascular system.

M. Rashid, T. Komiyama, T. Nagatomo, 2004, Pharmacology & therapeutics.

(Na+ + K+)-ATPase activity of newborn rabbit cardiac muscle.

T. Nagatomo, M. Sasaki, 1981, Biochemical medicine.

Isolation of sarcolemma from newborn rabbit cardiac muscle.

T. Tsuruhara, T. Nagatomo, M. Sasaki, 1981, Biochemical Medicine.

Lipid composition of sarcolemma, mitochondria and sarcoplasmic reticulum from newborn and adult rabbit cardiac muscle.

T. Nagatomo, M. Ikeda, K. Hattori, 1980, Biochemical medicine.

Characteristics of 125I-iodocyanopindolol binding to β-adrenergic and serotonin-1B receptors of rat brain: selectivity of β-adrenergic agents

Y. Nakashima, T. Nagatomo, H. Tsuchihashi, 1990 .

The sequence and correlation of the changes in several parameters of energy metabolism induced by ischemic insult in heart muscle.

H. Satoh, S. Imai, T. Nagatomo, 1984, Japanese heart journal.

Myotonia induced by diazacholesterol: increased (Na+ + K+)-ATPase activity of erythrocyte ghosts and development of cataracts.

T. Nagatomo, R. Andiman, J. Peter, 1973, Experimental neurology.

Experimental myotonia and hypocholesterolemic agents

T. Nagatomo, S. Dromgoole, D. Campion, 1975, Experimental Neurology.

Bopindolol: pharmacological basis and clinical implications.

M. Ishiguro, J. Suzuki, Y. Hosohata, 2006, Cardiovascular drug reviews.

Characterization of rat myocardial sarcolemma.

T. Tsuruhara, G. Tibbits, T. Nagatomo, 1981, Journal of molecular and cellular cardiology.

Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of lectins.

T. Nagatomo, H. Tsuchihashi, 1985, Japanese journal of pharmacology.

The affinity of betaxolol, a β1‐adrenoceptor‐selective blocking agent, for β‐adrenoceptors in the bovine trachea and heart

Y. Hosohata, T. Nagatomo, A. Narimatsu, 1993 .

Influence of polymeric effectors on binding of 3H-dihydroalprenolol to beta-adrenergic receptor of rat brain.

T. Nagatomo, H. Tsuchihashi, 1985, Japanese journal of pharmacology.

Practical access to four stereoisomers of naftidrofuryl and their binding affinity towards 5-hydroxytryptamine 2A receptor.

Hongbin Sun, Hequan Yao, L. Kong, 2012, Bioorganic & medicinal chemistry letters.

Pharmacological differences between Liu-Jun-Zi-Tang, a traditional Chinese herbal medicine, and domperidone on isolated guinea-pig ileum.

S. Kishioka, T. Maeda, M. Ozaki, 2006, Biological & pharmaceutical bulletin.

Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet.

N. Yagi, M. Kimura, T. Nagatomo, 1991, Journal of pharmacobio-dynamics.

Mutation of important amino acid residue of Asp104Lys in human beta(1)-adrenergic receptor triggers functional and constitutive inactivation.

Murad Hossain, Masanobu Ozaki, Mohiuddin Ahmed Bhuiyan, 2008, Biological & pharmaceutical bulletin.

Beta-blockers show inverse agonism to a novel constitutively active mutant of beta1-adrenoceptor.

M. Ishiguro, Maruf Ahmed, H. Kurose, 2006, Journal of pharmacological sciences.

Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.

Masanobu Ozaki, Mohiuddin Ahmed Bhuiyan, M. Ishiguro, 2006, Journal of pharmacological sciences.

(Na+ + K+)-ATPase activity in rats with 20,25-diazacholesterol-induced myotonia

T. Nagatomo, J. Peter, 1975, Experimental Neurology.

Effects of bunitrolol on adrenergic and serotonergic receptors.

J. Aono, T. Kawada, S. Imai, 1987, Japanese journal of pharmacology.

MCI-9042: high affinity for serotonergic receptors as assessed by radioligand binding assay.

Y. Takada, E. Sugiyama, T. Nagatomo, 1991, Journal of pharmacobio-dynamics.

Molecular modeling of SWR-0342SA, a β3-selective agonist, with β1- and β3-adrenoceptor

M. Ishiguro, Maruf Ahmed, T. Nagatomo, 2006 .

AT‐1015, a newly synthesized 5‐HT2 receptor antagonist, dissociates slowly from the 5‐HT2 receptor sites in rabbit cerebral cortex membrane

M. Nakazawa, M. Rashid, Masatomo Watanabe, 2002, The Journal of pharmacy and pharmacology.

Alpha‐1 adrenoceptor subtypes (high, low) in human benign prostatic hypertrophy tissue according to the affinities for prazosin

Yoshihiko Tomita, T. Mizusawa, A. Hatano, 1997, The Prostate.

(Na+ + K+)-ATPase in subcellular fractions of rat skeletal muscle

T. Nagatomo, J. Peter, 1975, Experimental Neurology.

Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.

Philippe Manivet, J. Launay, M. Ishiguro, 2003, Life sciences.

Changes in alpha 1- and beta 1-adrenergic receptors and calcium ion binding sites in the fetal myocardium of spontaneously hypertensive rats (SHR).

K. Watanabe, A. Shibata, K. Shimada, 1991, Journal of pharmacobio-dynamics.

Beta-receptor blocking potencies of the three newly synthesized beta-adrenergic antagonists (S-596, K-351, N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase.

S. Imai, T. Nagatomo, H. Nakahara, 1984, Japanese journal of pharmacology.

Alpha 1-adrenoceptor subtypes in bovine prostate.

T. Nagatomo, S. Baba, H. Tsuchihashi, 1992, The Journal of pharmacy and pharmacology.

Amino Acids of the Human α1d-Adrenergic Receptor Involved in Antagonist Binding

M. Ishiguro, Maruf Ahmed, Masatomo Watanabe, 2008 .

Tamsulosin: Assessment of Affinityof 3H-P razosin Binding to Two Alpha-1- Adrenoceptor Subtypes in the Canine Aorta

Kenichi Watanabe, Takashi Nakamura, T. Nagatomo, 1999, Pharmacology.

Asp125 and Thr130 in transmembrane domain 3 are major sites of alpha1b-adrenergic receptor antagonist binding.

Maruf Ahmed, M. Bhuiyan, Murad Hossain, 2007, Biological & pharmaceutical bulletin.

Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.

Y. Nakashima, T. Nagatomo, H. Tsuchihashi, 1990, Japanese journal of pharmacology.

Alpha-1 adrenoceptor subtypes in canine aorta.

T. Nagatomo, K. Maruyama, Y. Yagi, 1993, Japanese journal of pharmacology.

Binding and Functional Affinity of Sarpogrelate, Its Metabolite M-1 and Ketanserin for Human Recombinant Alpha-1-Adrenoceptor Subtypes

Fumiko Suzuki, Takafumi Nagatomo, T. Taniguchi, 2002, Pharmacology.

Characterization of 3H-dihydroalprenolol binding to beta-adrenergic receptors of rat brain: two binding sites of racemic propranolol in displacement experiments.

T. Nagatomo, H. Tsuchihashi, 1987, Chemical and pharmaceutical bulletin.

Comparison of Displacemental Potencies of Terazosin Enantiomers for α1-Adrenoceptor Subtypes

T. Nagatomo, K. Maruyama, Y. Yagi, 1994 .

Discrimination of α1-Adrenoceptor Subtypes in Rat Aorta and Prostate

Kenichi Watanabe, Masahiko Suzuki, T. Nagatomo, 1998, Pharmacology.

Two distinct α1-adrenoceptor subtypes in the human prostate : Assessment by radioligand binding assay using 3H-prazosin

T. Nagatomo, K. Hattori, K. Maruyama, 1996 .

Alterations of binding characteristics of alpha 1-,beta 1-adrenoceptors and Ca2+ binding sites in the myocardium of spontaneously hypertensive rats (SHR) by chronically administered bunazosin, atenolol, ketanserin and verapamil.

A. Shibata, K. Shimada, H. Wakabayashi, 1993, Biological & pharmaceutical bulletin.

α1‐Adrenoceptor Subtypes in Bovine Prostate

T. Nagatomo, S. Baba, H. Tsuchihashi, 1992 .

Tamsulosin: Assessment of Affinity of 3H-Prazosin Bindings to Two α1-Adrenoceptor Subtypes (α1H and α1L) in Bovine Prostate and Rat Heart and Brain

Kenichi Watanabe, Takashi Nakamura, K. Sugiyama, 1998 .

Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.

T. Nagatomo, H. Tsuchihashi, 1989, Journal of pharmacobio-dynamics.

Mutational analysis of the alpha 1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay.

Murad Hossain, Mohiuddin Ahmed Bhuiyan, Maruf Ahmed, 2008, Biological & pharmaceutical bulletin.

Identification of binding sites of prazosin, tamsulosin and KMD-3213 with alpha(1)-adrenergic receptor subtypes by molecular modeling.

M. Ishiguro, Maruf Ahmed, I. Muramatsu, 2002, Life sciences.

Nipradilol displays a unique pharmacological profile of affinities for the different alpha 1-adrenoceptor subtypes.

K. Sasaki, T. Nagatomo, H. Tsuchihashi, 1993, Japanese journal of pharmacology.

Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.

Y. Hosohata, T. Nagatomo, H. Tsuchihashi, 1991, Journal of pharmacobio-dynamics.

Comparison of alpha 1-adrenoceptors between rat brain and spleen.

T. Nagatomo, S. Baba, H. Tsuchihashi, 1991, Japanese journal of pharmacology.

Three binding sites of 125I-iodocyanopindolol, i.e. beta 1, beta 2-adrenergic and 5HT1B-serotonergic receptors in rat brain determined by the displacement and Scatchard analysis.

S. Imai, T. Nagatomo, H. Tsuchihashi, 1989, Journal of pharmacobio-dynamics.

Binding characteristics of 125I-iodocyanopindolol to beta-adrenergic receptors: biphasic Scatchard plots. II. Effects of selective antagonists.

T. Nagatomo, H. Tsuchihashi, 1987, Chemical & pharmaceutical bulletin.

Biphasic binding of 125I-iodocyanopindolol to beta-adrenergic receptors in rat cerebral cortical membranes. I. Assessment by the use of agonists.

T. Nagatomo, H. Tsuchihashi, 1987, Chemical & pharmaceutical bulletin.

Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.

T. Nagatomo, H. Tsuchihashi, M. Sasaki, 1985, Chemical & pharmaceutical bulletin.

Alpha-1 and beta-adrenergic receptor blocking potencies of bopindolol and its two metabolites (18-502 and 20-785) as assessed by radioligand binding assay methods.

K. Sasaki, Y. Hosohata, T. Nagatomo, 1995, General pharmacology.

Characteristics of 1251-lodocyanopindolol Binding to 8-Adrenergic and Serotonin-1 B Receptors of Rat Brain : Selectivity of 19-Adrenergic Agents

Y. Nakashima, T. Nagatomo, H. Tsuchihashi, 2006 .

Binding characteristics of alpha 1-adrenoceptors in bovine prostate using a radioligand binding assay.

T. Nagatomo, H. Tsuchihashi, J. Kinami, 1991, Journal of pharmacobio-dynamics.

Identification of Binding Sites of Bopindolol and Its Two Metabolites with β1-Adrenoceptors by Molecular Modeling: Comparison with β2 Adrenoceptors

M. Ishiguro, I. Muramatsu, Takashi Nakamura, 1999, Pharmacology.

Studies on relationships between chemical structure and beta-blocking potency of bopindolol and its two metabolites.

M. Ishiguro, Y. Hosohata, N. Takatsu, 1998, Life sciences.

Calcium channel blocking properties of SM-6586 in rat heart and brain as assessed by radioligand binding assay.

Y. Qu, K. Sugiyama, T. Nagatomo, 1993, Japanese journal of pharmacology.

Assessment of affinities and dissociation potencies of several 5-HT2 antagonists to and from M2 muscarinic receptor in rat heart membranes.

M. Nakazawa, M. Rashid, Habib Abul Muntasir, 2003, Biological & pharmaceutical bulletin.

Carbohydrate composition of sarcolemma of rat myocardium.

T. Nagatomo, H. Tsuchihashi, M. Sasaki, 1986, Biochemical medicine and metabolic biology.

Constitutively active mutant N111G of angiotensin II type 1 (AT(1)) receptor induces homologous internalization through mediation of AT(1)-receptor antagonist.

S. Miura, Takashi Nakamura, M. Bhuiyan, 2009, Journal of pharmacological sciences.

Mutagenesis of important amino acid reveals unconventional homologous internalization of beta(1)-adrenergic receptor.

M. Rashid, Takashi Nakamura, M. Bhuiyan, 2009, Life sciences.

Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.

Takashi Nakamura, M. Bhuiyan, Murad Hossain, 2010, Journal of pharmacological sciences.

Assessment of homologous internalization of constitutively active N111G mutant of AT(1) receptor.

M. Bhuiyan, T. Nagatomo, 2010, Methods in enzymology.

Binding Affinity of Candesartan, Losartan, Telmisartan and Valsartan with Angiotensin II Receptor 1 Subtype

M. Shahriar, M. Bhuiyan, T. Nagatomo, 2013 .

Selectivity of Valsartan to the Human Angiotensin II Type One Receptors as Assessed by Binding Affinity, Functional Activity and Molecular Modeling

Masatomo Watanabe, Murad Hossain, T. Nagatomo, 2010 .

Engineered mutation of some important amino acids in angiotensin II type 1 (AT1) receptor increases the binding affinity of AT1-receptor antagonists.

M. Ishiguro, Takashi Nakamura, M. Bhuiyan, 2010, Journal of pharmacological sciences.

Effects of sarpogrelate, a novel 5-HT2 antagonist, on 5-HT-induced endothelium-dependent relaxations in porcine coronary artery.

M. Nakazawa, M. Rashid, T. Nagatomo, 2002, Japanese journal of pharmacology.

Mechanism of inverse agonist action of sarpogrelate at the constitutively active mutant of human 5-HT2A receptor revealed by molecular modeling.

M. Ishiguro, M. Rashid, Habib Abul Muntasir, 2012, Biological & pharmaceutical bulletin.

Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells.

Y. Hara, T. Yamamoto, T. Nagatomo, 1997, Japanese journal of pharmacology.

Identification of amino acid residues important for sarpogrelate binding to the human 5-hydroxytryptamine2A serotonin receptor.

M. Rashid, T. Komiyama, Habib Abul Muntasir, 2006, Journal of pharmacological sciences.

A novel 5-HT(2) antagonist, sarpogrelate hydrochloride, shows inhibitory effects on both contraction and relaxation mediated by 5-HT receptor subtypes in porcine coronary arteries.

M. Nakazawa, M. Rashid, T. Nagatomo, 2000, Pharmacology.

Insurmountable antagonism of AT‐1015, a 5‐HT2 antagonist, on serotonin‐induced endothelium‐dependent relaxation in porcine coronary artery

M. Nakazawa, M. Rashid, T. Nagatomo, 2003, The Journal of pharmacy and pharmacology.

Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]-ethyl]-1-for myl-4-piperidinecarboxamide monohydrochloride monohydrate), on contraction and relaxation of pig coronary arteries induced by 5-HT and alpha-methylsero

M. Nakazawa, H. Kihara, T. Nagatomo, 2000, Biological & pharmaceutical bulletin.

Effects of ketanserin and 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monohydrochloride (SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin bindings to serotonergic (5HT1 and 5HT2) receptors in dog brain and aorta.

J. Aono, T. Nagatomo, H. Tsuchihashi, 1988, Chemical & pharmaceutical bulletin.

A non-selective β-blocker, bopindolol, exhibits high affinity to 5-HT1A receptor subtype in rat brain as assayed by competition binding experiments

K. Sasaki, J. Suzuki, Y. Hosohata, 1996 .

Site-directed mutagenesis of the serotonin 5-Hydroxytryptamine2c receptor: identification of amino acids responsible for sarpogrelate binding.

Maruf Ahmed, M. Nashimoto, M. Rashid, 2006, Biological & pharmaceutical bulletin.

Beneficial effects of diltiazem on the ischemic derangements of the myocardial metabolism assessed by 31P-NMR in the isolated perfused rat heart.

M. Nakazawa, S. Imai, T. Nagatomo, 1985, Japanese journal of pharmacology.